Monument, Therapeutics

Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Monument Therapeutics United Kingdom England United States of America New York

View original content:https://www.prnewswire.co.uk/news-releases/monument-therapeutics-secures-1m-investment-to-fund-its-schizophrenia-programme-and-drive-next-stage-of-growth-302275080.html

en | boerse | 67958552 |